SUMMARY -Contact skin lesions may be the consequences of contact with various irritants or allergens, or due to other factors (e.g., UV radiation, microbials), intrinsic factors (e.g., in autoimmune responses), or even their combination. Th ere are many substances related to irritant contact dermatitis (CD), causing irritant or toxic eff ects, e.g., chemical and physical agents, plants, phototoxic agents, airborne irritants, etc. Impaired barrier function (e.g., aberrancies in epidermal pH buff ering capabilities) also participates by promoting bacterial biofi lms and creating an environment favoring sensitization. Development of allergic CD skin lesions includes complex immune pathways and infl ammatory mediators, infl uenced by both genetic (predominantly fi laggrin mutations) and environmental triggers. In the pathogenesis of allergic CD, antimicrobial peptides play a prominent role; they are produced by various skin cells (e.g., keratinocytes, sebocytes) and move to infl amed lesions during an infl ammation process. Also, in allergic CD skin lesions, the skin shows diff erent types of immune responses to individual allergens, although clinical manifestations do not depend on the causative allergen type, e.g., nickel stimulates immune activation primarily of the Th 1/Th 17 and Th 22 components. Also important are alarmins, proteases, immunoproteomes, lipids, natural moisturizing factors, tight junctions, smoking, etc. We expect that future perspectives may reveal new pathogenetic factors and scientifi c data important for the workup and treatment of patients with CD.
Introduction
Contact dermatitis (CD) is an infl ammatory skin disease caused by chemicals or metal ions that exert irritant (toxic) eff ects, or by small reactive chemicals (contact allergens) that modify proteins and induce immune responses (predominantly by T-cell response) 1 . Consequently, CD may manifest as irritant CD and allergic CD, which may occur in acute or chronic forms.
Irritant CD is a nonspecifi c skin response to direct chemical skin damage and/with releasing infl ammatory mediators, while allergic CD is a delayed hypersensitivity reaction (type IV) to allergens, which includes immune responses (due to the interaction of T cells and cytokines) 1 . In diff erentiating the two diseases, it is pointed out that in irritant CD there are no immune reactions; no prior exposure to any substance (sensitization) is required; and most individuals exposed to such (usually aggressive) substance manifest a similar reaction 2 . Th ereby, contact skin lesions may be the consequences of contact with various irritants or allergens, or due to other factors (e.g., UV radiation, microbials), intrinsic factors (not always well-defi ned stimuli, e.g., in autoimmune responses), or even their combination [3] [4] [5] [6] [7] [8] [9] [10] [11] . When the occurrence of irritant CD and allergic CD is related to work activities, possible occupational CD may occur, related to diff erent workplace factors (e.g., alcohol-based disinfectants and detergents, latex gloves) 6, 9, 11 . Irritant CD and allergic CD are relatively frequent dermatoses. Irritant CD is more common than allergic CD. Although the incidence and prevalence of allergic CD in the general population are not precisely estimated, the prevalence of allergic CD is considered to be 15% to 25% 1 .
Th e Pathomechanisms of Contact Dermatitis
When irritant CD lesions occur after exposure to a substance (even in small concentrations), eff ects may accumulate due to repeated infl uence commonly leading to chronic skin damages and skin lesions. Irritant CD may manifest in a form of acute and chronic lesions. Th ere are many substances related to irritant CD, caused by their irritant or toxic eff ects, e.g., chemical agents, physical agents, plants, phototoxic agents, airborne irritants, etc.
1,2 . Th us, skin lesions may be caused by diff erent chemical agents (alkaline and acid solutions, organic solvents, tensides, croton oil), physical agents (UV radiation, x-rays, other ionizing radiation, laser rays, heat, cold and mechanical factors), food stuff s (e.g., asparagus, mustard, fruit juices), plants (e.g., agave, anemones, many others) and chemical warfare agents [4] [5] [6] [7] [8] [9] [10] [11] . Contact skin lesions due to phototoxic agents are also possible. An irritating impact of the environment resulting from airborne irritants may also occur; irritating dusts or fumes can damage uncovered skin (especially the face), causing edema and blisters.
Chronic irritant CD may be induced by any substance causing acute irritant CD that, when in small concentrations, can accumulate eff ects causing chronic skin damages (even water, in cases of frequent hand washing, working in water, taking shower, bathing, etc.) 2 . Consequently, it gradually changes, damaging and eliminating the skin protective barriers, particularly the protective lipid fi lm on the surface of the horny layer, the appertaining acid pH of that layer and the very horny layer itself [12] [13] [14] . On the other hand, in allergic CD, skin lesions are induced by immune reactions and by sensitization to some substance (allergen) mediated by T cells, occurring through the sensitization (aff erent) phase and the elicitation (eff erent) phase. Th e results of patch test, used for checking and proving the delayed hypersensitivity reaction (type IV) are the most important diagnostic indicators in diff erentiation between irritant and allergic CD 2 . Various substances can be allergens, particularly metal salts which interact weakly with skin proteins and thus form complexes. At the fi rst epicutaneous contact (the sensitization phase), the haptens stimulate keratinocyt es to express adhesion molecules (ICAM-1), proinfl ammatory cytokines (IL-1-, IL-1, TNF-, IL-6) and chemokines (IP-10, MCP-1, RANTES, CCL18) [15] [16] [17] [18] . Th e epidermal Langerhans cells then take over and ingest the neoantigen, process it, express MHC class I and II molecules, and migrate to the regional lymph nodes where they present the antigen to naïve T cells 2 . It turned out that, in allergic CD, keratinocytes secrete proinfl ammatory cytokines and chemokines that activate epidermal Langerhans cells and dermal vascular endothelial cells, which also express adhesion molecules and enable extravasation of the sensitized T cells (CD8, Tr1), mastocytes, basophils and immunocytes 19, 20 . During the next contact with the same hapten, in the dermis, the antigen-presenting cells (APCs) present the neoantigen to the memory CD8+ lymphocytes, which develop the eff ector cytotoxic T lymphocyte (CTL) function. Th ey bind with the keratinocytes expressing pMHC I and secreting interferon- (IFN-). Th e IFN- (secreted from the CTLs and from the activated macrophages) stimulates the expression of Fas molecules on keratinocytes and this (IFN-), in turn, binds the FasL expressed by the CTLs, which leads to apoptosis. In the fi nal phase, IFN- stimulates mastocytes and basophils to release lytic mediators; it also stimulates vasodilators (e.g., histamine) and chemokines to enable further infi ltration of cells and amplifi cation of an infl ammatory response 19, 20 . Within days, the macrophages migrate to the lymph nodes, where they express co-stimulatory molecules (CD80/86), present the antigen/allergen to the lymphocytes expressing late integrins [very late antigen (VLA)], 'homing' receptors (CD44), while also presenting the third infi ltration wave and triggering an adaptive immune response 1, 2, 21 . Th us, development of allergic CD skin lesions includes complex immune pathways, infl uenced by both genetic and environmental triggers 14 . Th ere are promi-nent roles of genetic variations and mutations (predominantly fi laggrin mutations) and impaired barrier function (e.g., aberrancies in epidermal pH buff ering capabilities), which may promote bacterial biofi lms and create an environment favoring sensitization 13, 22, 23 . Regarding genetics, according to research data, fi laggrin mutations (R501X, 2282del4, and R2447X) were identifi ed in 16.9% of patients with hand eczema and were signifi cantly associated with skin lesions (skin fi ssures on the fi ngers and heels).
Besides individual's predisposition, in infl ammatory skin diseases the lesion development process and involved factors (including cytokines and immune cells) depend on the trigger 3 . Also important are antimicrobial peptides and alarmins, skin tight junctions, natural moisturizing factors, immunoproteomes, proteases, lipids, smoking, etc. 24, 25 . For allergic CD also important is how the allergens pass through the cell membrane channels, depending on allergen type. For example, in the skin lesions occurring due to nickel allergy, the water-permeable nickel salts can pass through the cell membrane channels by using ion exchange and, together with other molecules (e.g., proteins, amino acids), be incorporated in the cell. It has also been observed that in an immune response to nickel allergy, Th 1 cells are more dominant than Th 2 cells 26 . Of the other factors involved in the pathogenesis of allergic CD, there is the role of antimicrobial peptides (AMPs) produced by various skin cells (e.g., keratinocytes, sebocytes) moving to the infl amed lesion area during an infl ammation process. As the AMPs act as protective antimicrobial barrier protecting the skin from bacterial and viral infections, they are called alarmins (because of their 'alarming' function and participation in inherent and acquired immune responses) 24, 27 . Also, the AMP expression is regulated with the microbial factor and infl ammatory cytokines. Some AMPs are generated if needed [as human -defensin (HBD) HBD-1 and HBD 2 as cathelicidin] 27 . It has been confi rmed that in infl amed CD lesions, skin tight junction proteins are often aff ected 3 . Th us, impaired barrier function is related to tight junctions, which form a barrier in the epidermal granular cell layer and are involved in keratinocyte proliferation, diff erentiation, cell-cell adhesion, and apoptosis.
It is also important that in irritant CD, occlusion decreases the skin barrier function and signifi cantly enhances the irritant-induced barrier damaging effects. Also, according to research data, in irritant-exposed fi elds the natural moisturizing factor values were signifi cantly decreased compared to non-exposed fi elds, indicating that occlusion enhanced decrease in the natural moisturizing factor 12 . Also, CD is characterized by barrier disruption and infl ammation, similar to atopic dermatitis (AD) and psoriasis, with unique epidermal signatures and common infl ammatory pathways identifi ed by transcriptomic profi ling 28 . Proteomic profi ling in subjects with both CD and AD identifi ed additional dysregulated proteins (compared to subjects with either condition alone), indicating an exacerbated infl ammation reaction. Unique serum proteomic signatures have been identifi ed that may distinguish between infl ammatory skin diseases (CD, AD) despite similar epidermal barrier disruption and epithelial infl ammation 28 .
Clinical Manifestations of Contact Dermatitis
Clinically, irritant CD can occur as an acute or chronic disease. Lesions may occur anywhere but commonly appear on the hands 2 . Acute irritant CD is typically characterized by erythema, blisters, pustules, hemorrhage, crusts, scales and erosions, and also with pruritus or even pain (Fig. 1) . Skin lesions in acute irritant CD are predominantly sharply bordered in the areas of contact (distant spread does not occur) and usually asymmetric.
On the other hand, chronic irritant CD is characterized by diff use or localized lesions with typically poorly defi ned erythematous scaly patches and plaques, dryness of skin, lichenifi cation and desquamation 2 . Irritant skin lesions commonly occur on the back of the hands and forearms (palms have greater intrinsic resistance). Th e disease is often asymmetric, with the dominant hand more aff ected. As the disease persists, lichenifi cation and fi ssures develop, with possible nail damage (paronychia with nail dystrophy, pitting, oil spots, etc.). Distant reactions usually do not occur and the disease is usually limited to the areas of repeated contact.
In allergic CD skin lesions, there are several diff erent clinical phases, i.e. erythematous phase with an unsharply delineated erythema or skin edema; and madidans phase characterized by erosions and moistening (Fig. 2) . In the next stage, crusts appear, followed by the fi nal, squamous stage, when the horny layer repairs itself. Acute allergic CD develops after hours. Skin lesions are initially asymmetric and limited to the area of contact, but often spread/disseminate later. In the case of severe reactions, there is swelling and blistering. Of the general symptoms in allergic CD, itching is very noticeable. Th e major clinical differences between irritant CD and allergic CD are the more rapid onset of irritant CD and the tendency of allergic CD to spread. It is typical that the widespread reaction is usually symmetric, although the primary reaction is not.
When skin lesions of allergic CD persist, chronic allergic CD can develop (Fig. 3) . Skin lesions may 
Fig. 4. Histology of irritant contact dermatitis skin lesion (punch biopsy, H&E, X100).
creep up subtly with no acute phase or appear on top of chronic irritant CD. Typical features include a symmetric pattern, less sharp borders, and distant spread. Also, distant lesions may occur, which are typically papulovesicular. Th e main feature of chronic allergic CD is epidermal reaction with lichenifi cation, fi ssures, and pruritus 2 .
Histologic Analysis of Contact Dermatitis Lesions
Histologic analysis of biopsy specimens of skin lesions in irritant CD and allergic CD shows nonspecifi c pictures, usually including spongiosis, spongiotic bubbles, numerous neutrophils in the epidermis, swollen capillaries in the subepidermal dermis, and perivascular lymphocytic infi ltrates 29 ( Figs. 4 and 5 ). Histopathology of acute irritant CD reveals spongiosis and vesicles or blisters in the epidermis, or sometimes epidermal necrosis or even no epidermis. In the dermis, there is a perivascular infi ltrate with exocytosis of neutrophils and lymphocytes, along with vasodilatation and edema. Generally, in the cases when epidermal damage predominates, it indicates toxic damage 2 . However, histopathology of chronic irritant CD of the hand does not show histologic clues to the etiology of chronic irritant CD. Uncommon fi nding are acute changes (such as spongiosis and edema), while expected fi nding are reactive epidermal changes (such as lichenifi cation), along with a dermal perivascular lymphohistiocytic infi ltrate.
Histopathology of allergic CD shows lymphocytic perivascular infi ltrate, high dermal edema, and epidermal spongiosis and exocytosis in the dermis 2 . When lesions persist in chronic allergic CD, the epidermis shows reactive change (acanthosis, hyperkeratosis, parakeratosis) with little spongiosis and dermal mixed infl ammatory infi ltrate.
Histologic fi nding of irritant CD lesions shows moderate spongiosis, intracellular edema, exocytosis, progression of infl ammatory infi ltrate into the epidermis, and a reduced number of CD4+ Langerhans cells in the epidermis. Similarly, the following can be found in allergic CD lesions: spongiosis with predominating microvesicles, focal distribution of infl ammatory infi ltrate in the epidermis and sparse pustulation, and reduced numbers of CD4+ Langerhans cells that grow with time. In comparison, irritant CD lesions histologically commonly present with mild spongiosis, epidermal cell necrosis, epidermal neutrophilic infi ltration, whereas in allergic CD dermal infl ammatory infi ltrates are predominated with lymphocytes and other mononuclear cells 1 .
Immunohistochemistry of Contact Dermatitis Skin Lesions
Immunohistochemical analyses are a useful research method because they enable localization of specifi c active antigens by use of targeted antibodies, thus providing additional information on individual diseases, including CD. In addition to diagnostic purposes, immunohistochemistry is also used in scientifi c research, helping us gain a better insight into the distribution and localization of biomarkers and expressions of individual proteins in various tissues [30] [31] [32] . In both irritant CD and allergic CD, immunohistochemistry of skin lesions shows infi ltration of predominantly CD4+ T cells and some CD8+T cells. In their acute phase, there is an increased expression of IL-2, ICAM-1 and HLA-DR on keratinocytes 33 . In irritant CD lesions, a decrease in the number of CD4+ Langerhans cells can be seen. As for allergic CD, the number of CD4+ Langerhans cells is reduced in the beginning, but it later increases. In irritant CD and allergic CD, the cytokines [primarily interleukins (ILs)] also have an important role in the infl ammatory processes. Although the types of cytokines involved in irritant CD are somewhat diff erent from those in allergic CD, some cytokines are important for both types of CD. For instance, IL-2 and IFN- (generated by irritation of damaged keratinocytes) participate in the migration and activation of infl ammatory cells and initiating infl ammatory responses, thus participating in both CD types 34 . Th ere are minor diff erences too; staining for IL-1 receptor antagonist is more expressed in allergic CD (in the dermis in a later stage), whereas IFN- is more expressed in infl ammatory responses in irritant CD 35 . Analysis of skin biopsies in allergic CD (polymerase chain reaction and immunohistochemistry) in patients with positive patch test established higher levels of the IFN-, IL-4, IL-17A, IL-9 and PU.1 cytokines in comparison with normal skin. Immunohistochemically, PU.1+, CD3+, PU.1+ and CD4+ cells were identifi ed in biopsies of patients with allergic CD. As regards allergic CD, it was also established that IL-9 had a direct eff ect on Th 1 lymphocytes, as well as on stimulation of IL-4 secretion, the regulatory role of which is important for Th 1 lymphocytes 36 . Th us, immune response in CD is complex and involves diff erent cells 1, 2, 15, 24 . Some studies have shown that, in allergic CD, determining mRNA expressions for IL-1 has a major role in the induction phase of the disease, as it increases the expression of MHC II molecules on Langerhans cells and induces molecular adhesion [through intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), endothelial leukocyte adhesion molecule-1 (ELAM-1), and lymphocyte function antigen-3 (LFA-3)] 15 . More recent studies have reported evidence that in allergic CD skin lesions, skin shows diff erent types of reactions and diff erent immune responses to individual allergens 37 . Although clinical manifestations do not depend on the causative allergen type, skin lesions show a marked immune process/polarization depending on the allergen. Th us, nickel stimulates immune activation primarily of the Th 1/Th 17 and Th 22 components.
A recent research supports the participation of NK cells in skin lesions 26 . Some animal studies emphasize the role of NK cells (also called iNK T cells and Va14iNK T cells), which are the T cells that express receptors for CD161c. Th us, NK T cells recognize the glycolipids presented in the context of CD1d (MHC class I-similar molecules) and, upon activation, the Th 1 and Th 2 molecules are produced, as well as IFN- and IL-4 that regulate the immune response in skin lesions 26, 38 .
Conclusion
However, although irritant and allergic CD have been studied for numerous biomarkers and factors (genetics, infl ammatory mediators, antimicrobial peptides and alarmins, skin tight junctions, natural moisturizing factors, smoking, etc.), convincing, specifi c indicators and biomarkers have not yet been confi rmed. We expect that future perspectives may reveal new pathogenetic factors and scientifi c data important for the workup and treatment of patients with CD.
